Prot #BPS-314d-MR-PAH-302: A multicenter, double-blind, randomized, placebo-controlled, Phase 3 study to assess the efficacy and safety of oral BPS-314d-MR added-on to treprostinil, inhaled (Tyvaso®) in subjects with pulmonary arterial hypertension

Project: Research project

Project Details

StatusActive
Effective start/end date8/12/152/12/21

Funding

  • Lung Biotechnology PBC (Prot #BPS-314d-MR-PAH-302)